Kevin Healy
Institution Name:
University of California, Berkeley
Total Awards:
1
Award Value:
$899,581
Awards as PI
| Program Type | Institution | Grant Title | Award Value |
|---|---|---|---|
| Progression Award - Discovery Stage Research Projects | University of California, Berkeley | Safety “Clinical Trial” of the Cardiac Liability of COVID19 Polytherapy | $224,500 |
| Quest - Discovery Stage Research Projects | University of California, Berkeley | Human Cardiac Chip for Assessment of Proarrhythmic Risk | $899,581 |
Total: $1,124,081.00 |
Publications
- Sci Rep 2018 Inversion and computational maturation of drug response using human stem cell derived cardiomyocytes in microphysiological systems. (PubMed: 30514966)
- Front Pharmacol 2019 Improved Computational Identification of Drug Response Using Optical Measurements of Human Stem Cell Derived Cardiomyocytes in Microphysiological Systems. (PubMed: 32116671)
- bioRxiv 2020 In Vitro Safety "Clinical Trial" of the Cardiac Liability of Hydroxychloroquine and Azithromycin as COVID19 Polytherapy. (PubMed: 33398282)
- Clin Transl Sci 2021 In vitro safety "clinical trial" of the cardiac liability of drug polytherapy. (PubMed: 33786981)
- Front Pharmacol 2021 Heart Muscle Microphysiological System for Cardiac Liability Prediction of Repurposed COVID-19 Therapeutics. (PubMed: 34421592)